Eczema: FDA approves Dupixent injection
by Press Release from Outbreak News Today on (#2HC7W)
The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable. Dupixent can be used with or without topical corticosteroids. "FDA's approval of Dupixent ["]
The post Eczema: FDA approves Dupixent injection appeared first on Outbreak News Today.